Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « considered »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
considerations < considered < considering  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000003 (2020) Charlotte Girard-Guyonvarc'H ; Michele Iudici[Targeted therapies for connective tissue diseases and vasculitis].
000014 (2020) Puja Mehta ; Jessica J. MansonWhat Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
000042 (2020) Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000134 (2020) Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000139 (2020) Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
000145 (2020) Yunze Li [République populaire de Chine] ; Yixin Yang [République populaire de Chine] ; Jinwan Guo [République populaire de Chine] ; Xuejiao Guo [République populaire de Chine] ; Zhiying Feng [République populaire de Chine] ; Xuli Zhao [République populaire de Chine]Spinal NF-kB upregulation contributes to hyperalgesia in a rat model of advanced osteoarthritis
000177 (2020) Kaveh Hajifathalian ; Srihari Mahadev ; Robert E. Schwartz ; Shawn Shah ; Kartik Sampath ; Felice Schnoll-Sussman ; Robert S. Brown Jr ; David Carr-Locke ; David E. Cohen ; Reem Z. SharaihaSARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000235 (2020) Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis]Pharmacotherapy in COVID-19; A narrative review for emergency providers
000263 (2020) Gilson Gonçalves Dos Santos [États-Unis] ; Lauriane Delay [États-Unis] ; Tony L. Yaksh [États-Unis] ; Maripat Corr [États-Unis]Neuraxial Cytokines in Pain States
000266 (2020) Jessica Vandenhaute [Belgique] ; Carine H. Wouters [Belgique] ; Patrick Matthys [Belgique]Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
000267 (2020) Emanuele Nicastri ; Nicola Petrosillo ; Tommaso Ascoli Bartoli ; Luciana Lepore ; Annalisa Mondi ; Fabrizio Palmieri ; Gianpiero D Ffizi ; Luisa Marchioni ; Silvia Murachelli ; Giuseppe Ippolito ; Andrea AntinoriNational Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
000274 (2020) Meng Hsuan Kuo [Taïwan] ; Chih-Wei Tseng [Taïwan] ; Chi-Hui Lee [Taïwan] ; Chien-Hsueh Tung [Taïwan] ; Kuo-Chih Tseng [Taïwan] ; Ning-Sheng Lai [Taïwan]Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis
000276 (2020) Giacomo Bellani [Italie] ; Tài Pham [France] ; John G. Laffey [Irlande (pays)]Missed or delayed diagnosis of ARDS: a common and serious problem
000290 (2020) Federico Alberici [Italie] ; Elisa Delbarba [Italie] ; Chiara Manenti [Italie] ; Laura Econimo [Italie] ; Francesca Valerio [Italie] ; Alessandra Pola [Italie] ; Camilla Maffei [Italie] ; Stefano Possenti [Italie] ; Simone Piva [Italie] ; Nicola Latronico [Italie] ; Emanuele Focà [Italie] ; Francesco Castelli [Italie] ; Paola Gaggia [Italie] ; Ezio Movilli [Italie] ; Sergio Bove [Italie] ; Fabio Malberti [Italie] ; Marco Farina [Italie] ; Martina Bracchi [Italie] ; Ester Maria Costantino [Italie] ; Nicola Bossini [Italie] ; Mario Gaggiotti [Italie] ; Francesco Scolari [Italie]Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
000309 (2020) Florian Moretto ; François-Xavier Catherine ; Clémentine Esteve ; Mathieu Blot [France] ; Lionel Piroth [France]Isolated Anti-HBc: Significance and Management
000319 (2020) Paula Sanchis ; Olaya Fernández-Gayol [États-Unis] ; Gemma Comes ; Anna Escrig ; Mercedes Giralt ; Richard D. Palmiter ; Juan HidalgoInterleukin-6 Derived from the Central Nervous System May Influence the Pathogenesis of Experimental Autoimmune Encephalomyelitis in a Cell-Dependent Manner
000390 (2020) Patricia Richi [Espagne] ; Oriol Alonso [Espagne] ; María Dolores Martín [Espagne] ; Laura González-Hombrado [Espagne] ; Teresa Navío [Espagne] ; Marina Salido [Espagne] ; Jesús Llorente [Espagne] ; Cristina Andreu-Vázquez [Espagne] ; Cristina García-Fernández [Espagne] ; Ana Jiménez-Diaz [Espagne] ; Leticia Lojo [Espagne] ; Laura Cebrián [Espagne] ; Israel Thuissard-Vasallo [Espagne] ; María José Martínez De Aramayona [Espagne] ; Tatiana Cobo [Espagne] ; Marta García-Castro [Espagne] ; Patricia Castro [Espagne] ; M Nica Fernández-Castro [Espagne] ; Scar Illera [Espagne] ; Martina Steiner [Espagne] ; Santiago Mu Oz-Fernández [Espagne]Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study.
000450 (2020) Marta Garrido-Jare O [Espagne] ; Antonio Sahuquillo-Torralba [Espagne] ; Rabab Chouman-Arcas [Espagne] ; Iván Castro-Hernández [Espagne] ; José Miguel Molina-Moreno [Espagne] ; Margarita Llavador-Ros [Espagne] ; María Dolores G Mez-Ruiz [Espagne] ; José Luis L Pez-Hontangas [Espagne] ; Rafael Botella-Estrada [Espagne] ; Miguel Salavert-Lleti [Espagne] ; Javier Pemán-García [Espagne]Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital
000454 (2020) He Huang [République populaire de Chine] ; Heng-Wei Wu [République populaire de Chine] ; Yong-Xian Hu [République populaire de Chine]Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
000505 (2020) Giulia Lanzolla [Italie] ; Guia Vannucchi [Italie] ; Ilaria Ionni [Italie] ; Irene Campi [Italie] ; Federica Sileo [Italie] ; Elisa Lazzaroni [Italie] ; Michele Marin [Italie]Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "considered" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "considered" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    considered
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021